
Onligo 2.5mg Tablet MD
Marketer
Kuresys Labs
Salt Composition
Olanzapine (2.5mg)
Overview Onligo 2.5mg Tablet MD
Onligo 2.5mg Tablet MD treats schizophrenia (a mental illness causing hallucinations, delusions, and impaired thinking/behavior) and mania. This medication can be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Abrupt cessation is unsafe and may exacerbate symptoms; consult your doctor before stopping. Common side effects include dry mouth, constipation, muscle stiffness, and agitation. Initial blood pressure drops upon positional changes are possible; rise slowly from sitting or lying. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until the effects are known. Weight gain, elevated blood sugar, and increased cholesterol are potential side effects, mitigated by healthy diet and exercise. Rare, but serious, side effects include dangerously high blood sugar and seizures.
Primary Ingredients of Onligo 2.5mg Tablet MD
No information provided. Please provide the text you wish me to rephrase.
Uses of Onligo 2.5mg Tablet MD
Managing Manic Episodes | Managing Schizophrenia
Major Benefits of Onligo 2.5mg Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Onligo 2.5mg Tablet MD can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Onligo 2.5mg Tablet MD:
- Dizziness
- Sleepiness
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Dryness in mouth
- Weight gain
- Increased prolactin level in blood
- Constipation
- Muscle stiffness
- Restlessness
- Tremors
How to use Onligo 2.5mg Tablet MD:
Administer this medication precisely as your physician prescribes, adhering to both the dosage and treatment schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth, allowing it to dissolve; do not ingest it whole. Onligo 2.5mg Tablet MD can be consumed with or without food, however, consistent daily timing is recommended.
How Onligo 2.5mg Tablet MD works:
Onligo 2.5mg MD tablets are an atypical antipsychotic medication. Their mechanism of action involves modulating dopamine and serotonin neurotransmitter levels, thereby enhancing cognitive function, emotional regulation, and overall behavior.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Onligo 2.5mg Tablet MD is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Onligo 2.5mg Tablet MD during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Onligo 2.5mg Tablet MD while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Onligo 2.5mg Tablet MD might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Onligo 2.5mg Tablet MD poses no safety concerns for use in patients with renal impairment; dose modification is unnecessary.
LiverSAFE IF PRESCRIBED
The use of Onligo 2.5mg Tablet MD in individuals with liver impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Onligo 2.5mg Tablet MD :
Should you forget a dose of Onligo 2.5mg Tablet MD, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Onligo 2.5mg Tablet MD
| Label | Value |
|---|---|
| Chemical Category | Thienobenzodiazepine Analog |
| Developing Habits | No. |
| Type of Therapy | Central Nervous System (CNS) Neurology |
